INVH vs MBRX · P/E 42, rev $1.48B vs $8.2M cap
Invitation Homes Inc (INVH) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
Invitation Homes Inc (INVH) is a reit - residential company listed on US.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Latest reported INVH revenue for 2026-06-30 was $1.48B. Net income was $379.4M. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
INVH currently screens at market cap $19.99B and trailing P/E 41.8. MBRX currently screens at market cap $8.2M.
Not investment advice. Open the INVH and MBRX stock pages for the full models.
Not investment advice.